ETON
Price:
$31.59
Market Cap:
$865.32M
Eton Pharmaceuticals, Inc. functions as a specialized pharmaceutical enterprise, primarily focused on the invention and market introduction of medical treatments for rare diseases. Its current product lineup features Biorphen and Rezipres, both phenylephrine injections designed to counter significant hypotension arising from vasodilation during anesthesia. The company also offers Carglumic Acid, a treatment for acute and chronic hyperammonemia linked to N-acetylglutamate Synthase deficiency. Further marketed solutions include Alkindi Sprinkle, which serves as a replacement therapy for adrenocortical insufficiency in children younger than 17; EPRONTIA, a liquid formulation of topiramate; and ...[Read more]
Industry
Biotechnology
IPO Date
2018-11-13
Stock Exchange
NASDAQ
Ticker
ETON
According to Eton Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -526.50. This represents a change of -3018.53% compared to the average of 18.04 of the last 4 quarters.
The mean historical PE Ratio of Eton Pharmaceuticals, Inc. over the last ten years is -44.86. The current -526.50 PE Ratio has changed 117.27% with respect to the historical average. Over the past ten years (40 quarters), ETON's PE Ratio was at its highest in in the March 2026 quarter at 108.33. The PE Ratio was at its lowest in in the December 2024 quarter at -145.54.
Average
-44.86
Median
-15.25
Minimum
-120.01
Maximum
-3.08
Discovering the peaks and valleys of Eton Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.43%
Maximum Annual PE Ratio = -3.08
Minimum Annual Increase = -85.79%
Minimum Annual PE Ratio = -120.01
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -98.89 | 9.61% |
| 2024 | -90.22 | -24.82% |
| 2023 | -120.01 | 1.43% |
| 2022 | -7.86 | -85.79% |
| 2021 | -55.31 | 805.75% |
| 2020 | -6.11 | -12.51% |
| 2019 | -6.98 | 126.41% |
| 2018 | -3.08 | -79.78% |
The current PE Ratio of Eton Pharmaceuticals, Inc. (ETON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-103.04
5-year avg
-74.46
10-year avg
-44.86
Eton Pharmaceuticals, Inc.’s PE Ratio is less than RAPT Therapeutics, Inc. (-14.81), less than Fulcrum Therapeutics, Inc. (-3.45), less than Neumora Therapeutics, Inc. Common Stock (-1.44), less than Lexicon Pharmaceuticals, Inc. (-29.45), less than Omeros Corporation (7.29), less than Ocugen, Inc. (-5.41), less than Monopar Therapeutics Inc. (-34.04), less than Lineage Cell Therapeutics, Inc. (-4.85), less than ADC Therapeutics S.A. (-1.18), less than Bicycle Therapeutics plc (-1.29),
| Company | PE Ratio | Market cap |
|---|---|---|
| -14.81 | $959.26M | |
| -3.45 | $186.68M | |
| -1.44 | $329.81M | |
| -29.45 | $852.86M | |
| 7.29 | $632.20M | |
| -5.41 | $409.61M | |
| -34.04 | $400.40M | |
| -4.85 | $316.61M | |
| -1.18 | $133.55M | |
| -1.29 | $281.05M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eton Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Eton Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Eton Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Eton Pharmaceuticals, Inc. (ETON)?
What is the highest PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?
What is the 3-year average PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?
What is the 5-year average PE Ratio for Eton Pharmaceuticals, Inc. (ETON)?
How does the current PE Ratio for Eton Pharmaceuticals, Inc. (ETON) compare to its historical average?